A Randomised Open-label Multi-centre Comparative Study to Evaluate Cycle Control of 2 Dosages of Estetrol Combined With Either P1 or P2, Compared to a Combined Oral Contraceptive Containing E2V and DNG.

Trial Profile

A Randomised Open-label Multi-centre Comparative Study to Evaluate Cycle Control of 2 Dosages of Estetrol Combined With Either P1 or P2, Compared to a Combined Oral Contraceptive Containing E2V and DNG.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Aug 2017

At a glance

  • Drugs Estetrol (Primary) ; Drospirenone; Estradiol valerate/dienogest; Levonorgestrel
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Acronyms FIESTA study
  • Sponsors Estetra S.A.
  • Most Recent Events

    • 27 Feb 2012 Actual patient number (396) added as reported by ClinicalTrials.gov.
    • 23 Sep 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
    • 23 Sep 2011 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top